Outcome following local injection of a liquid amnion allograft for treatment of equine tendonitis or desmitis – 100 cases

• Published in: BMC veterinary research 2022-11, Vol.18 (1), p.1-391, Article 391
• Main Authors: Duddy, Hugh. R, Schoonover, Mike. J, Hague, Brent. A
• Format: Article
• Language: English
• Subjects: Amnion; Amniotic fluid; Anesthesia; Autografts; Care and treatment; Clinical trials; Cytokines; Growth factors; Health aspects; Horse; Horses; Injection; Injuries; Lesions; Ligament; Ligaments; Mesenchyme; Patient outcomes; Questionnaires; Regenerative medicine; Statistical analysis; Stem cells; Tendinitis; Tendon; Veterinarians
• ISSN: 1746-6148; 1746-6148
• DOI: 10.1186/s12917-022-03480-5

Background Tendon and ligament injuries are significant causes of loss of use and early retirement in performance horses. Amniotic fluid and tissue are excellent sources of growth factors and cytokines important in tendon and ligament healing. Thus, an equine-origin liquid amnion allograft (ELAA) may be beneficial in the treatment of equine tendonitis and desmitis. Objectives of this study were to report the outcome achieved (i.e. ability to return to work) for horses diagnosed with tendonitis or desmitis lesions treated with local injection of ELAA and to compare these outcomes to those reported for other regenerative medicine modalities. Methods A prospective, multi-center, non-blinded clinical trial was conducted. Equine veterinarians at 14 sites were selected to participate in the data collection for the trial. Criterion for inclusion was a horse presenting with lameness which was attributed to tendonitis or desmitis by diagnostic anesthesia and/or imaging. These horses were subsequently treated by local injection of the lesion with ELAA by the attending veterinarian. Standardized questionnaires describing each horse's signalment, discipline, ability to return to work, and any adverse events were completed and submitted by the attending veterinarian following a minimum of six months of follow-up. The current literature was reviewed to identify clinical studies reporting outcomes of equine tendonitis/desmitis lesions treated with other regenerative therapies. Contingency table analyses were performed comparing outcomes. Results Questionnaires for 100 horses with 128 tendonitis and desmitis lesions met the inclusion criteria. Of these, 72 horses with 94 lesions returned to or exceeded their original level of work, 10 horses with 13 lesions returned to work but could not perform to previous standards, and 18 horses with 20 lesions did not return to work as a result of the injury. No differences were observed when outcome of horses treated with ELAA were compared to those of similar studies using other regenerative therapies. Conclusions Treatment of tendonitis and desmitis lesions by local injection of ELAA resulted in similar outcomes for horses returning to previous level of performance as other regenerative modalities such as mesenchymal stem cells, platelet-rich plasma, and autologous conditioned serum; however, blinded placebo-controlled studies are indicated. Keywords: Regenerative medicine, Horse, Tendon, Ligament